Cough, Cold and Allergy (Hay Fever) Remedies in South Africa

PROSPECTS

Economic uncertainty and a willingness to self-medicate driving category growth

Cough, cold and allergy (hay fever) remedies continues to record double-digit current value growth in 2018. Category growth continues to be fuelled by new product development and increasing self-medication.

High incidence of HIV and climatic conditions drive growth in antihistamines/allergy remedies

Antihistamines/allergy remedies (systemic) has continued to perform well in 2018, registering further double-digit current value growth, with it set to continue performing strongly over the forecast period. This growth is being fuelled by increasing consumer awareness of allergies and how to tackle them.

Cough remedies sees strong growth despite restrictions

Cough remedies is another category that continues to record double-digit growth in 2018, with consumers looking for affordable and effective relief. Nevertheless, products containing codeine and acetaminophen remain highly regulated in South Africa.

COMPETITIVE LANDSCAPE

Adcock Ingram maintains its leading position

Adcock Ingram continues to lead cough, cold and allergy (hay fever) remedies in 2018 with brands including Corenza C in combination products and Alcophyllex in cough remedies. The company benefits from a very wide and diverse product portfolio, offering remedies at various price points so as to appeal to different household budgets.

Multinationals dominate sales although traditional medicine has a strong foothold in rural South Africa

While local company Adcock Ingram remains the overall leader in cough, cold and allergy (hay fever) remedies, multinationals such as Johnson & Johnson, GlaxoSmithKline and Reckitt Benckiser account for the largest share. Despite the strong presence of their international brands, traditional medicines remain very popular among locals, especially those in rural areas.

Private label continues to grow but from a low base

Private label products from Woolworths, mainly in medicated confectionery, and Clicks continue to account for a very small value share in 2018. However, these private label ranges saw strong growth over the review period, with sales being driven by consumers looking for the best value.

Files are delivered directly into your account within a few minutes of purchase.

---